TriMas Corporation (TRS)

Currency in USD
39.93
+1.87(+4.91%)
Closed·
40.32+0.39(+0.98%)
·
TRS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
36.8940.09
52 wk Range
30.4345.43
Key Statistics
Prev. Close
39.93
Open
37.75
Day's Range
36.89-40.09
52 wk Range
30.43-45.43
Volume
693.09K
Average Volume (3m)
486.1K
1-Year Change
14.3471%
Book Value / Share
39.32
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TRS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
45.00
Upside
+12.70%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

TriMas Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 45.00
(+12.70% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
KeyBanc
Buy38.00-4.83%-MaintainFeb 26, 2026
KeyBanc
Buy38.00-4.83%45.00MaintainNov 13, 2025
KeyBanc
Buy45.00+12.70%-UpgradeAug 13, 2025

TriMas Corporation Earnings Call Summary for Q2/2026

  • TriMas Q2 2026 adjusted EPS of $0.52 beat estimates by 10.64%, but revenue of $174.6M missed by 2.15%; shares fell 8.26% to $36.08 in premarket.
  • Operating profit surged 29% to $14.9M with margin expanding 180 bps to 8.5%, driven by cost cuts and share buybacks despite flat organic sales growth.
  • Company raised full-year adjusted EPS guidance floor to $1.60-$1.70 from $1.50-$1.70; maintained 3-6% sales growth target and 300+ bps margin expansion.
  • Norris Cylinder sales outlook increased to 6-9% growth from 3-6%, citing strong orders and Made in USA positioning, despite staffing and throughput challenges.
  • CEO Snyder emphasized strategic focus on customer success, operational excellence, and profitability; company exploring M&A in life sciences with $846M net cash.
Last Updated: 30/07/2026, 16:14
Read Full Transcript

Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
0.52 / 0.47
Revenue / Forecast
174.6M / 178.44M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 23.57%
Dividend Yield
0.40%
Industry Median 3.13%
Annualised payout
0.16
Paid quarterly
5-Years Growth
-
Growth Streak

TRS Income Statement

Compare TRS to Peers and Sector

Metrics to compare
TRS
Peers
Sector
Relationship
P/E Ratio
17.2x25.9x3.6x
PEG Ratio
0.01−0.150.00
Price/Book
1.0x1.6x1.6x
Price / LTM Sales
2.2x1.0x1.3x
Upside (Analyst Target)
12.7%18.8%43.2%
Fair Value Upside
Unlock17.5%2.7%Unlock

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace and defense, and industrial markets worldwide. The company operates through Packaging and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Aarts Packaging, Intertech, Omega Plastics, and Rapak brands. The Specialty Products segment designs, manufactures, and distributes steel cylinders for use in transportation, storage, and dispensing of packaged and compressed gases under the Norris Cylinder brand. It sells its products through a direct sales force, third-party agents, and distributors. The company was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
14.83M40.42%592.07M
Other Institutional Investors
19.93M54.32%795.78M
Public Companies & Retail Investors
1.93M5.26%77.00M
Total
36.69M100.00%1.46B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bank of America Corporation9.82%3,602,705143,856
Allspring Global Investments, LLC6.84%2,509,919100,221

People Also Watch

253.60
SIMO
-0.59%
544.84
WDC
+2.21%
289.52
AEIS
+5.56%
65.890
CECO
+0.53%

FAQ

What Is the TriMas (TRS) Stock Price Today?

The TriMas stock price today is 39.93 USD.

What Stock Exchange Does TriMas Trade On?

TriMas is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for TriMas?

The stock symbol for TriMas is "TRS."

What Is the TriMas Market Cap?

As of today, TriMas market cap is 1.43B USD.

What Is TriMas's Earnings Per Share (TTM)?

The TriMas EPS (TTM) is 23.57.

When Is the Next TriMas Earnings Date?

TriMas will release its next earnings report on Oct 22, 2026.

From a Technical Analysis Perspective, Is TRS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has TriMas Stock Split?

TriMas has split 0 times.

How Many Employees Does TriMas Have?

TriMas has 2500 employees.

What is the current trading status of TriMas (TRS)?

As of Aug 03, 2026, TriMas (TRS) is trading at a price of 39.93 USD, with a previous close of 39.93 USD. The stock has fluctuated within a day range of 36.89 USD to 40.09 USD, while its 52-week range spans from 30.43 USD to 45.43 USD.

What Is TriMas (TRS) Price Target According to Analysts?

The average 12-month price target for TriMas is 45.00 USD, with a high estimate of 45 USD and a low estimate of 45 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +12.70% Upside potential.

What Is the TRS Premarket Price?

TRS's last pre-market stock price is 40.32 USD. The pre-market share volume is 90.00, and the stock has decreased by 0.39, or 0.98%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.